Category Medical Devices

Thubrikar Aortic Valve Announces Authorization to Expand the TAVI-1 CE Mark Trial with the Precision 2™ Delivery Catheter

-Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ (Optimum TAVI…

Read MoreThubrikar Aortic Valve Announces Authorization to Expand the TAVI-1 CE Mark Trial with the Precision 2™ Delivery Catheter

Neuranics Unleashes 24/7 Heart Monitoring Revolution at CES 2024 with a Wearable Magnetocardiography (MCG) Development Platform

Magnetic sensor specialist startup Neuranics has announced that it will launch a magnetic sensor development kit that will record the magnetic activity of the heart and wirelessly transfer this over…

Read MoreNeuranics Unleashes 24/7 Heart Monitoring Revolution at CES 2024 with a Wearable Magnetocardiography (MCG) Development Platform

The Largest Plastic Surgery Information Platform in South Korea Launches UNNI a Global K-Medical Information App for Foreigners

The Largest Plastic Surgery Information Platform in South Korea Launches ‘UNNI’, a Global K-Medical Information App for Foreigners Healing Paper, the operator of the largest plastic surgery information platform in…

Read MoreThe Largest Plastic Surgery Information Platform in South Korea Launches UNNI a Global K-Medical Information App for Foreigners

Vertex Announces European Medicines Agency Validation for Marketing Authorization Application Extension for KAFTRIO® in Combination With Ivacaftor to Include People With Cystic Fibrosis and Responsive Rare Mutations

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency (EMA) has validated a Type II variation application to the Marketing Authorization for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in combination with ivacaftor. The application…

Read MoreVertex Announces European Medicines Agency Validation for Marketing Authorization Application Extension for KAFTRIO® in Combination With Ivacaftor to Include People With Cystic Fibrosis and Responsive Rare Mutations

BIOVECTRA Launches Specialized Capabilities in mRNA Drug Product Development and Biomanufacturing

BIOVECTRA Launches Specialized Capabilities in mRNA Drug Product Development and Biomanufacturing Today BIOVECTRA celebrates the completion of its $90 million plus biologics expansion at the company’s new state-of-the-art Biomanufacturing Centre…

Read MoreBIOVECTRA Launches Specialized Capabilities in mRNA Drug Product Development and Biomanufacturing

Phase Genomics Advances Breakthrough Cytogenomics with the Element AVITI System for Acute Myeloid Leukemia

Phase Genomics, Inc., a global innovator for industry-leading genomic solutions, today announced the presentation of new data from the proximity ligation sequencing-based OncoTerra cytogenomics platform on the leading-edge AVITI next-generation…

Read MorePhase Genomics Advances Breakthrough Cytogenomics with the Element AVITI System for Acute Myeloid Leukemia

Recor Medical Announces U.S. Launch and First Commercial Cases of Paradise Ultrasound Renal Denervation Therapy

Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), today announced the first commercial uses of Recor’s Paradise™ Ultrasound Renal Denervation (uRDN) system for…

Read MoreRecor Medical Announces U.S. Launch and First Commercial Cases of Paradise Ultrasound Renal Denervation Therapy